Hospitals will receive $100 billion in emergency funding from the coronavirus relief package. The money could offset revenue losses from canceled elective surgeries and the costs from a flood of COVID-19 patients needing critical care. (Politico)
COVID-19 cases worldwide have surpassed 500,000. That number has doubled in just over a week from 200,000 last Thursday. More than 22,000 people have died from the illness globally. (CNBC)
Bristol Myers Squibb has won approval for its multiple sclerosis drug, Zeposia, from the Food and Drug Administration. BMS said it is delaying the launch of Zeposia due to the coronavirus outbreak. When it hits the market it will compete with similar MS drugs from Novartis, Teva, Roche and Biogen. (BioPharma Dive)
The U.S. will likely see another cycle of COVID-19, but may be able to avoid lockdowns, said HHS infectious disease leader Dr. Anthony Fauci. He said, based on what the government is learning now, the next outbreak could be contained at a low level “which would mean we won’t have to lock down again.” (Reuters)
For this year’s Agency 100, we’re asking agencies to design an album cover for their firm. The album cover will be featured in the Agency 100 and the Ones To Watch alongside each agency’s profile and in a digital gallery. Submissions are due April 20. (MM&M)
